Berto Acquisition Corp. II (LIXT) compared with its closest peers (RNTX, SPRO, PMVP, XBIT, OSTX). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Rein Therapeutics Inc. (RNTX) | $71.52M | -0.6 |
| Spero Therapeutics, Inc. (SPRO) | $70.93M | 9.6 |
| PMV Pharmaceuticals, Inc. (PMVP) | $70.56M | -0.9 |
| XBiotech Inc. (XBIT) | $69.82M | -1.6 |
| OS Therapies Incorporated (OSTX) | $69.19M | -1.4 |
| MediciNova, Inc. (MNOV) | $68.66M | -5.4 |
| Boundless Bio, Inc. (BOLD) | $68.24M | -0.5 |
| Cypherpunk Technologies Inc. (CYPH) | $67.13M | 16.5 |
| Heron Therapeutics, Inc. (HRTX) | $64.55M | -10.8 |
| Talphera, Inc. (TLPH) | $62.02M | — |
| Sector P/E (Financials) | 15.1 |
| Industry P/E (Trading) | 35.3 |
LIXT overview · LIXT earnings · LIXT financials · LIXT KPIs · LIXT investor relations · LIXT ownership · LIXT filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.